The clinical decision support system (CDSS) market accounted for USD 1.7 Billion in 2020 and is expected to reach USD 3.3 Billion by 2028, growing at a CAGR of 8.7 % from 2021 to 2028.
The Global clinical decision support system (CDSS) market accounted for USD 1.7 Billion in 2020 and is expected to reach USD 3.3 Billion by 2028, growing at a CAGR of 8.7 % from 2021 to 2028.
To support the health professionals in decision-making in the health sector, a system is developed which is the clinical decision support system. To analyse0 the clinical data and diagnose various diseases of the patients, the clinicians interact with the clinical decision support system. The adoption of the system was due to the passing of the acts such as Health Information Technology for Economic and Clinical Health Act (HITECH Act) in 2009. The system can be used in various stages such as before the diagnosis, during the diagnosis, and after diagnosis in order to understand the connection between the patient's past medical history and the current medical data.
Covid-19 pandemic has led to a tremendous shift in the healthcare sector. As the world was hit by the wave of coronavirus, the recognition and need to deploy quality healthcare for each and every one has increased a lot. Demand for accurate diagnosis and treatment of diseases along with time efficiency has increased a lot during the pandemic across the globe. Clinical decision support systems work best under this model as it allows the healthcare professionals to check and monitor the patients using non- invasive devices which are digitally connected. Thus, the pandemic has boosted the demand for the clinical decision support system market.
There are various factors leading to the growth of the clinical decision support system market. As more countries are developing, they are focussing on quality healthcare which can be provided to the residents. The people are also becoming more aware and conscious of the healthcare and facilities which are being provided to them. Rising adoption rate as well as integration of IT in the healthcare sector is adding to the growth of the clinical decision support system market. Features such as time efficiency and less chances of medical error are also boosting the demand of the market.
The on-premise segment held a share of over 55% in 2020. Delivery mode segment comprises of on premise, cloud based and web based. Out of this on premise hold the largest market share. As the data is highly sensitive, the information privacy and security is highest for the on premise delivery mode. Cloud based may lead to data breach due to the number of cyber attacks prevailing. Thus, on premise is a widely used and deployed delivery mofe.
The main components of CDSS are software, hardware, and services by providers of the system. The hardware includes computer and other electronic gadgets used to run the software; the software component performs data analysis and provides decision support to organization; and the services involve maintenance, upgrading, and troubleshooting for both the hardware as well as the software by the provider.
The Asia pacific region is projected to grow at a CAGR of 7.9 % over the forecast period. The developing region has witnessed a rise in the usage of technology along with the improving healthcare services. Various new market players are emerging in the region that will add to the overall growth of the market. The presence of a large geriatric population with increasing chronic diseases which requires high end healthcare services for diagnosis accuracy as well as time efficiency. Also, awareness of the government towards the technology advancement and quality healthcare will add to the growth of the clinical decision support system market in the region.
The North America region is expected to be growing significantly for the clinical decision support system (CDSS) market. The presence of a large number of market players is also going to contribute significantly towards the growth of the clinical decision support system (CDSS) market in the region. North America is a technologically advanced region, which means the availability of technologically advanced healthcare IT solutions. Increasing disposable incomes in the region is also contributing to the growth of the clinical decision support system (CDSS) market.
Some of the key players in the clinical decision support system (CDSS) market are Cerner Corporation, Epic Systems Corporation, Zynx Health, Allscripts Healthcare Solutions Inc., IBM, McKesson Corporation, Siemens Healthineers, Meditech, Philips Healthcare, and Wolters Kluwer Health, among others.
These companies adopt various strategies in order to boost their presence and capitalization. For instance, Philips Healthcare recently announced a long-term strategic partnership with Westchester Medical Center Health Network, providing equipment, medical and information technology optimization services, clinical education, and operational consulting services.
By Component
By Product
By Delivery Mode
By Model
By Type
By Level of Interactivity
By Application
By Region
FrequentlyAsked Questions
The clinical decision support system (CDSS) market was valued at 1.7 USD Billion in 2020.
The clinical decision support system (CDSS) market is expected to reach USD 3.3 Billion by 2028, growing at a CAGR of 8.7 % between 2021 to 2028.
Some of the key factors driving the clinical decision support system (CDSS) market growth are, integration of IT in the healthcare services along with the advantage of unique features of the clinical decision support systems.
The Asia Pacific region held a substantial share of the market in 2020. The technological advancement and emergence of numerous market players is going to contribute significantly towards the growth of the clinical decision support system (CDSS)market in the region.
Some of the major companies operating in the clinical decision support system (CDSS) market are Cerner Corporation, Epic Systems Corporation, Zynx Health, Allscripts Healthcare Solutions Inc., IBM, McKesson Corporation, Siemens Healthineers, Meditech, Philips Healthcare, and Wolters Kluwer Health, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed